logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Absence Epilepsy

    FiltersReset Filters
    16 results

    • acetazolamide

      (acetaZOLAMIDE)
      Zydus Pharmaceuticals (USA) Inc.
      Usage: Acetazolamide is indicated as an adjunctive treatment for edema related to congestive heart failure and drug use, various forms of epilepsy, and glaucoma. It is also used to prevent or alleviate symptoms of acute mountain sickness in climbers.

    • clonazepam

      (CLONAZEPAM)
      Alembic Pharmaceuticals Inc.
      Usage: Clonazepam orally disintegrating tablets are indicated for treating seizure disorders, including Lennox-Gastaut syndrome and myoclonic seizures, as well as panic disorder with or without agoraphobia. Its long-term efficacy has not been systematically studied, prompting periodic reevaluation for ongoing use.

    • clonazepam

      (Clonazepam)
      Aurobindo Pharma Limited
      Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic and myoclonic seizures, and as an adjunct for absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term effectiveness has not been extensively studied.

    • clonazepam

      (Clonazepam)
      Teva Pharmaceuticals USA, Inc.
      Usage: Clonazepam is indicated for the treatment of seizure disorders such as Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as for panic disorder, with or without agoraphobia. Its efficacy for long-term use beyond nine weeks has not been systematically studied.

    • clonazepam

      (Clonazepam)
      Chartwell RX, LLC
      Usage: Clonazepam is indicated for the treatment of seizure disorders, including Lennox-Gastaut syndrome, akinetic, and myoclonic seizures, as well as absence seizures unresponsive to succinimides. It is also used to treat panic disorder, with or without agoraphobia, characterized by recurrent panic attacks.

    • clonazepam

      (Clonazepam)
      NorthStar RxLLC
      Usage: Clonazepam is indicated for treating seizure disorders, including Lennox-Gastaut syndrome, akinetic, myoclonic, and certain absence seizures. It is also used for panic disorder, with or without agoraphobia, characterized by unexpected panic attacks. Long-term efficacy has not been systematically studied. Regular reevaluation is advised.

    • divalproex sodium

      (Divalproex Sodium)
      Aurobindo Pharma Limited
      Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in epilepsy (complex partial and absence seizures). They are also used for migraine prophylaxis but not for acute treatment. Not suitable for pregnant women or those planning pregnancy.

    • divalproex sodium

      (divalproex sodium)
      Bionpharma Inc.
      Usage: Divalproex sodium is indicated for treating manic episodes in bipolar disorder, managing complex partial and absence seizures in epilepsy, and for migraine prophylaxis. Long-term efficacy in mania is not established. Use is contraindicated in pregnant women and those of childbearing potential not on effective contraception due to risks of fetal harm.

    • ethosuximide

      (Ethosuximide)
      Epic Pharma, LLC
      Usage: Ethosuximide is indicated for the control of absence (petit mal) epilepsy.

    • valproate sodium

      (VALPROATE SODIUM)
      Fresenius Kabi USA, LLC
      Usage: Valproate sodium injection is indicated for intravenous treatment of epilepsy, including complex partial seizures, simple and complex absence seizures, and as adjunct therapy for multiple seizure types. It is not recommended for women who are pregnant or of childbearing potential unless other treatments are ineffective.